Gayle P. Orczyk

706 total citations
14 papers, 521 citations indexed

About

Gayle P. Orczyk is a scholar working on Reproductive Medicine, Endocrinology, Diabetes and Metabolism and Genetics. According to data from OpenAlex, Gayle P. Orczyk has authored 14 papers receiving a total of 521 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Reproductive Medicine, 4 papers in Endocrinology, Diabetes and Metabolism and 4 papers in Genetics. Recurrent topics in Gayle P. Orczyk's work include Estrogen and related hormone effects (4 papers), Ovarian function and disorders (4 papers) and Reproductive Physiology in Livestock (3 papers). Gayle P. Orczyk is often cited by papers focused on Estrogen and related hormone effects (4 papers), Ovarian function and disorders (4 papers) and Reproductive Physiology in Livestock (3 papers). Gayle P. Orczyk collaborates with scholars based in United States, France and Canada. Gayle P. Orczyk's co-authors include Harold R. Behrman, Roy O. Greep, Alain Patat, Evelyn J. Ellis‐Grosse, Dominique Guyader, Gordon J. F. MacDonald, James Ermer, George A. Hedge, Patti Sullivan and Vann P. Parker and has published in prestigious journals such as Hepatology, Endocrinology and Clinical Pharmacology & Therapeutics.

In The Last Decade

Gayle P. Orczyk

14 papers receiving 465 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gayle P. Orczyk United States 9 209 136 133 114 114 14 521
MacDonald Pc United States 9 131 0.6× 38 0.3× 54 0.4× 132 1.2× 140 1.2× 15 655
K Korte Germany 12 114 0.5× 47 0.3× 79 0.6× 24 0.2× 91 0.8× 25 451
R. Sangha United Kingdom 9 164 0.8× 75 0.6× 225 1.7× 83 0.7× 29 0.3× 10 768
Annie Benhaïm France 15 150 0.7× 115 0.8× 22 0.2× 160 1.4× 92 0.8× 37 515
Jane E. Mijovic Canada 11 135 0.6× 66 0.5× 163 1.2× 27 0.2× 53 0.5× 20 588
Ramesh B. Ghodgaonkar United States 12 59 0.3× 57 0.4× 76 0.6× 161 1.4× 28 0.2× 29 505
E.H.D. Cameron United Kingdom 17 281 1.3× 70 0.5× 21 0.2× 88 0.8× 478 4.2× 43 918
Wenxiao Wu China 12 75 0.4× 83 0.6× 45 0.3× 41 0.4× 26 0.2× 29 410
Eva Svensson Sweden 7 71 0.3× 63 0.5× 14 0.1× 141 1.2× 50 0.4× 9 626
R. Kilpatrick United Kingdom 11 63 0.3× 62 0.5× 33 0.2× 32 0.3× 152 1.3× 26 524

Countries citing papers authored by Gayle P. Orczyk

Since Specialization
Citations

This map shows the geographic impact of Gayle P. Orczyk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gayle P. Orczyk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gayle P. Orczyk more than expected).

Fields of papers citing papers by Gayle P. Orczyk

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gayle P. Orczyk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gayle P. Orczyk. The network helps show where Gayle P. Orczyk may publish in the future.

Co-authorship network of co-authors of Gayle P. Orczyk

This figure shows the co-authorship network connecting the top 25 collaborators of Gayle P. Orczyk. A scholar is included among the top collaborators of Gayle P. Orczyk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gayle P. Orczyk. Gayle P. Orczyk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Orczyk, Gayle P., et al.. (2014). A double‐blind, randomized, ascending, multiple‐dose study of bazedoxifene in healthy postmenopausal women. Clinical Pharmacology in Drug Development. 3(4). 262–269. 8 indexed citations
2.
Ermer, James, et al.. (2006). Pharmacokinetics and safety of tanaproget, a nonsteroidal progesterone receptor agonist, in healthy women. Contraception. 74(5). 414–418. 5 indexed citations
3.
Ermer, James, H. Lee, William DeMaio, et al.. (2003). Bazedoxifene Acetate Metabolic Disposition in Healthy, Postmenopausal Women. Clinical Pharmacology & Therapeutics. 73(2). 15 indexed citations
4.
Ermer, James, et al.. (2003). Bazedoxifene Acetate Dose Proportionality in Healthy, Postmenopausal Women. Clinical Pharmacology & Therapeutics. 73(2). 23 indexed citations
5.
Guyader, Dominique, Alain Patat, Evelyn J. Ellis‐Grosse, & Gayle P. Orczyk. (2002). Pharmacodynamic effects of a nonpeptide antidiuretic hormone V2 antagonist in cirrhotic patients with ascites. Hepatology. 36(5). 1197–1205. 60 indexed citations
6.
Muralidharan, G., et al.. (1999). Pharmacokinetics and pharmacodynamics of a novel vasopressin receptor antagonist, VPA-985, in healthy subjects. Clinical Pharmacology & Therapeutics. 65(2). 189–189. 6 indexed citations
7.
Keaton, Mark, T.D. Brown, Jesse C. Craig, et al.. (1990). Phase II study of carbetimer in non-small cell lung cancer. Investigational New Drugs. 8(4). 385–386. 2 indexed citations
8.
Hanauske, A.-R., Gary M. Clark, John B. Craig, et al.. (1988). Phase I clinical trial of carbetimer.. PubMed. 48(18). 5353–7. 7 indexed citations
9.
Orczyk, Gayle P., John P. Mordes, & Christopher Longcope. (1987). Aromatase Activity in a Rat Leydig Cell Tumor*. Endocrinology. 120(4). 1482–1489. 6 indexed citations
10.
Orczyk, Gayle P., et al.. (1977). In VivoInhibition of Thyroid Secretion by Indomethacin∗. Endocrinology. 100(4). 1060–1067. 21 indexed citations
11.
Mellin, T.N., Gayle P. Orczyk, M Hichens, & Harold R. Behrman. (1976). Serum profiles of luteinizing hormone, progesterone and total estrogens during the canine estrous cycle. Theriogenology. 5(4). 175–187. 17 indexed citations
12.
Behrman, Harold R., Gayle P. Orczyk, & Roy O. Greep. (1972). Effect of synthetic gonadotrophin-releasing hormone (Gn-Rh) on ovulation blockade by aspirin and indomethacin. Prostaglandins. 1(4). 245–258. 44 indexed citations
13.
Orczyk, Gayle P. & Harold R. Behrman. (1972). Ovulation blockade by aspirin or indomethacin - in vivo evidence for a role of prostaglandin in gonadotrophin secretion. Prostaglandins. 1(1). 3–20. 254 indexed citations
14.
Behrman, Harold R., Gayle P. Orczyk, Gordon J. F. MacDonald, & Roy O. Greep. (1970). Prolactin Induction of Enzymes Controlling Luteal Cholesterol Ester Turnover. Endocrinology. 87(6). 1251–1256. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by MacDonald Pc Breakdown of academic impact, for papers by K Korte Breakdown of academic impact, for papers by R. Sangha Breakdown of academic impact, for papers by Annie Benhaïm Breakdown of academic impact, for papers by Jane E. Mijovic Breakdown of academic impact, for papers by Ramesh B. Ghodgaonkar Breakdown of academic impact, for papers by E.H.D. Cameron Breakdown of academic impact, for papers by Wenxiao Wu Breakdown of academic impact, for papers by Eva Svensson Breakdown of academic impact, for papers by R. Kilpatrick
Rankless by CCL
2026